T. Levine

411 total citations
10 papers, 310 citations indexed

About

T. Levine is a scholar working on Rheumatology, Molecular Biology and Neurology. According to data from OpenAlex, T. Levine has authored 10 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in T. Levine's work include Glycogen Storage Diseases and Myoclonus (2 papers), Biochemical and Molecular Research (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). T. Levine is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (2 papers), Biochemical and Molecular Research (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). T. Levine collaborates with scholars based in United States, United Kingdom and Hungary. T. Levine's co-authors include Feifei Gao, J. D. Keene, C C Carson, M. Al-Lozi, Julaine Florence, Alan Pestronk, Timothy M. Miller, Mikula K. Stambuk, Glenn Lopate and Elijah W. Stommel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

T. Levine

9 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Levine United States 5 148 86 41 26 25 10 310
Kazuki Nakahara Japan 8 107 0.7× 30 0.3× 24 0.6× 32 1.2× 25 1.0× 34 305
Adam Mp 6 180 1.2× 30 0.3× 27 0.7× 37 1.4× 46 1.8× 286 388
Ardinger Hh United States 6 192 1.3× 30 0.3× 27 0.7× 37 1.4× 46 1.8× 287 402
Bean Ljh 6 180 1.2× 29 0.3× 26 0.6× 37 1.4× 46 1.8× 285 386
Bird Td United States 6 162 1.1× 25 0.3× 23 0.6× 35 1.3× 41 1.6× 244 342
Sietske H. Kevelam Netherlands 10 283 1.9× 100 1.2× 15 0.4× 32 1.2× 19 0.8× 11 473
Mefford Hc 6 163 1.1× 24 0.3× 21 0.5× 35 1.3× 40 1.6× 239 337
Maryam Sedghi Iran 11 176 1.2× 70 0.8× 39 1.0× 32 1.2× 30 1.2× 46 338
Christina von Gertten Sweden 7 156 1.1× 120 1.4× 18 0.4× 56 2.2× 15 0.6× 8 328
Linda Manwaring United States 8 136 0.9× 33 0.4× 23 0.6× 17 0.7× 83 3.3× 15 374

Countries citing papers authored by T. Levine

Since Specialization
Citations

This map shows the geographic impact of T. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Levine more than expected).

Fields of papers citing papers by T. Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Levine. The network helps show where T. Levine may publish in the future.

Co-authorship network of co-authors of T. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of T. Levine. A scholar is included among the top collaborators of T. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Levine. T. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Aggarwal, Rohit, Christina Charles‐Schoeman, Joachim Schessl, et al.. (2021). OP0008 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF IVIG 10% IN PATIENTS WITH DERMATOMYOSITIS. THE PRODERM STUDY: RESULTS ON EFFICACY AND SAFETY. Annals of the Rheumatic Diseases. 80. 4–5. 6 indexed citations
2.
Charles‐Schoeman, Christina, Joachim Schessl, Zsuzsanna Bata‐Csörgõ, et al.. (2020). AUTOIMMUNE MYOPATHIES. Neuromuscular Disorders. 30. S133–S133. 2 indexed citations
3.
Levine, T., Joseph Tauber, Pei‐Ching Chang, et al.. (2019). D451 CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN SEVERE ALLERGIC CONJUNCTIVITIS AND COMORBID ATOPIC DISEASES. Annals of Allergy Asthma & Immunology. 123(5). S17–S17. 1 indexed citations
4.
Bradley, Walter G., et al.. (2017). Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of l-Serine. Neurotoxicity Research. 33(1). 192–198. 26 indexed citations
5.
Kishnani, Priya S., Mark A. Tarnopolsky, K Sivakumar, et al.. (2012). T.P.46 A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease. Neuromuscular Disorders. 22(9-10). 852–852. 1 indexed citations
7.
Levine, T., Nicole Hank, David Saperstein, Walter G. Bradley, & Paul Alan Cox. (2012). A Pilot Trial of Zinc in Patients with ALS (P04.153). Neurology. 78(Meeting Abstracts 1). P04.153–P04.153.
8.
Levine, T.. (2006). Peripheral neuropathies in Waldenstrom's macroglobulinaemia. Journal of Neurology Neurosurgery & Psychiatry. 77(2). 224–228. 58 indexed citations
9.
Pestronk, Alan, Julaine Florence, T. Levine, et al.. (2004). Sensory exam with a quantitative tuning fork. Neurology. 62(3). 461–464. 82 indexed citations
10.
Gao, Feifei, C C Carson, T. Levine, & J. D. Keene. (1994). Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.. Proceedings of the National Academy of Sciences. 91(23). 11207–11211. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026